Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease
Cells · 2023
DOI: 10.3390/cells12202501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Katie Uhl und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA. Hauptthemen laut MEDLINE: COVID-19, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a pathological condition wherein lung injury precipitates the deposition of scar tissue, ultimately leading to a decline in pulmonary function. Existing research indicates a notable exacerbation in the clinical prognosis of IPF patients following infection with COVID-19. This investigation employed bulk RNA-sequencing methodologies to describe the transcriptomic profiles of small airway cell cultures derived from IPF and post-COVID fibrosis patients. Differential gene expression analysis unveiled heightened activation of pathways associated with microtubule assembly and interferon signaling in IPF cell cultures. Conversely, post-COVID fibrosis cell cultures exhibited distinctive characteristics, including the upregulation of pathways linked to extracellular matrix remodeling, immune system response, and TGF-β1 signaling. Notably, BMP signaling levels were elevated in cell cultures derived from IPF patients compared to non-IPF control and post-COVID fibrosis samples. These findings underscore the molecular distinctions between IPF and post-COVID fibrosis, particularly in the context of signaling pathways associated with each condition. A better understanding of the underlying molecular mechanisms holds the promise of identifying potential therapeutic targets for future interventions in these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.
- Corewell Health Medical Group, Grand Rapids, MI 49503, USA.
- Richard DeVos Lung Transplant Program, Corewell Health, Grand Rapids, MI 49503, USA.
- Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
ORCID-Profile: Shreya Paithankar, Mohamed Abdelgied, Maximiliano Tamae Kakazu, Cameron Lawson
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Cystic Fibrosis Foundation
Zitieren
APA
Uhl, K., Paithankar, S., Leshchiner, D., Jager, T. E., Abdelgied, M., Dixit, B., Marashdeh, R., Luo-Li, D., Tripp, K., Peraino, A. M., Tamae Kakazu, M., Lawson, C., Chesla, D. W., Luo-Li, N., Murphy, E. T., Prokop, J., Chen, B., Girgis, R. E., & Li, X. (2023). Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease. Cells. https://doi.org/10.3390/cells12202501
Vancouver
Uhl K, Paithankar S, Leshchiner D, Jager TE, Abdelgied M, Dixit B, et al. Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease. Cells. 2023. doi:10.3390/cells12202501
BibTeX
@article{Uhl2023,
author = {Uhl, Katie and Paithankar, Shreya and Leshchiner, Dmitry and Jager, Tara E and Abdelgied, Mohamed and Dixit, Bhavna and Marashdeh, Raya and Luo-Li, Dewen and Tripp, Kaylie and Peraino, Angela M and Tamae Kakazu, Maximiliano and Lawson, Cameron and Chesla, Dave W and Luo-Li, Ningzhi and Murphy, Edward T and Prokop, Jeremy and Chen, Bin and Girgis, Reda E and Li, Xiaopeng},
title = {Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12202501}
}
EUVIMED